Nantahala Capital Management LLC Has $761,000 Stock Holdings in NeuroOne Medical Technologies Co. (NASDAQ:NMTC)

Nantahala Capital Management LLC trimmed its holdings in shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC) by 20.7% in the second quarter, according to its most recent filing with the SEC. The firm owned 950,962 shares of the company’s stock after selling 247,950 shares during the period. Nantahala Capital Management LLC owned approximately 3.42% of NeuroOne Medical Technologies worth $761,000 as of its most recent filing with the SEC.

NeuroOne Medical Technologies Stock Down 2.9 %

Shares of NMTC opened at $0.99 on Tuesday. The company has a 50-day moving average price of $0.81 and a two-hundred day moving average price of $0.96. The stock has a market cap of $27.56 million, a price-to-earnings ratio of -1.71 and a beta of 0.70. NeuroOne Medical Technologies Co. has a 12 month low of $0.60 and a 12 month high of $2.00.

NeuroOne Medical Technologies (NASDAQ:NMTC) last posted its earnings results on Wednesday, August 14th. The company reported ($0.10) EPS for the quarter. The company had revenue of $0.83 million for the quarter. NeuroOne Medical Technologies had a negative return on equity of 276.12% and a negative net margin of 308.51%.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.